Isoform-selective HDAC inhibition up-regulates CD26 expression on multiple myeloma cells and augments cytotoxic efficacy by humanized monoclonal antibody.

被引：0
|
作者：
Nishida, Hiroko [1 ]
Fujiwara, Mari [1 ]
Hayashi, Mutsumi [1 ]
Sakamoto, Michiie [1 ]
机构：
[1] Keio Univ, Sch Med, Tokyo, Japan
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5473
引用
收藏
页数：1
相关论文
共 16 条
  • [1] CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma
    Nishida, Hiroko
    Hayashi, Mutsumi
    Morimoto, Chikao
    Sakamoto, Michiie
    Yamada, Taketo
    BLOOD CANCER JOURNAL, 2018, 8
  • [2] CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma
    Hiroko Nishida
    Mutsumi Hayashi
    Chikao Morimoto
    Michiie Sakamoto
    Taketo Yamada
    Blood Cancer Journal, 8
  • [3] HDAC Inhibition Involves CD26 Induction on Multiple Myeloma Cells Via the c-Myc/Sp1-Mediated Prompter Activation and Overcomes Therapeutic Resistance By Humanized Antibody
    Nishida, Hiroko
    Suzuki, Reiko
    Nakajima, Kiyora
    Hayashi, Mutsumi
    Sakamoto, Michiie
    BLOOD, 2022, 140 : 3151 - 3152
  • [4] CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1
    Ohnuma, K
    Yamochi, T
    Uchiyama, M
    Nishibashi, K
    Yoshikawa, N
    Shimizu, N
    Iwata, S
    Tanaka, H
    Dang, NH
    Morimoto, C
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (39) : 14186 - 14191
  • [5] Upregulation of CD38 Expression on Multiple Myeloma Cells By the HDAC Inhibitor Ricolinostat Augments the Efficacy of Daratumumab
    Garcia-Guerrero, Estefania
    Danhof, Sophia
    Schreder, Martin
    Perez-Simon, Jose A.
    Einsele, Hermann
    Hudecek, Michael
    BLOOD, 2017, 130
  • [6] HDAC Inhibition Induces CD26 Expression on Multiple Myeloma Cells via the c-Myc/Sp1-mediated Promoter Activation
    Nishida, Hiroko
    Suzuki, Reiko
    Nakajima, Kiyora
    Hayashi, Mutsumi
    Morimoto, Chikao
    Yamada, Taketo
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (02): : 349 - 364
  • [7] Humanized Anti-CD26 Monoclonal Antibody Has Anti-Myeloma Efficacy for the Treatment of High-Risk Multiple Myeloma
    Nishida, Hiroko
    Hayashi, Mutsumi
    Morimoto, Chikao
    Sakamoto, Michiie
    Yamada, Taketo
    BLOOD, 2017, 130
  • [8] Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab
    Garcia-Guerrero, Estefania
    Goetz, Ralph
    Doose, Soeren
    Sauer, Markus
    Rodriguez-Gil, Alfonso
    Nerreter, Thomas
    Kortuem, K. Martin
    Perez-Simon, Jose A.
    Einsele, Hermann
    Hudecek, Michael
    Danhof, Sophia
    LEUKEMIA, 2021, 35 (01) : 201 - 214
  • [9] Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab
    Estefanía García-Guerrero
    Ralph Götz
    Sören Doose
    Markus Sauer
    Alfonso Rodríguez-Gil
    Thomas Nerreter
    K. Martin Kortüm
    José A. Pérez-Simón
    Hermann Einsele
    Michael Hudecek
    Sophia Danhof
    Leukemia, 2021, 35 : 201 - 214
  • [10] Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab
    Estefanía García-Guerrero
    Ralph Götz
    Sören Doose
    Markus Sauer
    Alfonso Rodríguez-Gil
    Thomas Nerreter
    K. Martin Kortüm
    José A. Pérez-Simón
    Hermann Einsele
    Michael Hudecek
    Sophia Danhof
    Leukemia, 2022, 36 : 297 - 297
12